Dentsply Sirona, Zimmer Biomet and Medtronic are Dominating the Global Dental Membrane and Bone Graft Substitute Market in 2019

Global Dental Membrane and Bone Graft Substitute Market is expected to grow with the CAGR of 9.1% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below.

Access full Report @ https://www.databridgemarketresearch.com/reports/global-dental-membrane-bone-graft-substitute-market

Global dental membrane and bone graft substitute market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.   

The major players dealing in global dental membrane and bone graft substitute market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition, agreement, business expansion, award and recognition into the market. This helped companies to maximize the sales with enhanced product portfolio. For instance, in March 2018, DENTSPLY SIRONA Inc. signed an acquisition agreement in order to acquire OraMetrix, a company provides 3-D technology solutions for orthodontic care. This acquisition helped the company to provide end to end digital workflow to dental professionals in order to provide best dental treatment solution.

Dentsply Sirona is the dominating player in global dental membrane and bone graft substitute market. The other key players existing in the market includes Zimmer Biomet, Medtronic, OUSIA, Matricel GmbH, LifeNet Health, ACE Surgical Supply Co., Inc., Institut Straumann AG, Geistlich Pharma AG, NovaBone Products, LLC, Collagen Matrix, Inc., Implantdirect (A Subsidiary of Envista), Nobel Biocare Services AG (A Subsidiary of Danaher), BioHorizons, OSTEOGENICS BIOMEDICAL Bioteck S.p.A., B&B Dental Implant Company, Augma Biomaterials, Biomatlante, and Curasan, Inc. (A Subsidiary of curasanAG), among others.

Dentsply Sirona

Dentsply Sirona headquarter is in North Carolina, U.S and was founded in 1899. The company is engaged in manufacturing of dental products in order to empower dental professionals to provide better, safe, faster dental care. The company has two business segments including consumables segment, technologies & equipment segment. In this technologies & equipment segment is the market focussed segment. The company has wide product portfolio such as preventive, restorative, orthodontics, endodontics, implants, prosthetics, CAD/CAM, Imaging systems, treatment centers, instruments, digital impression, in which implants is the market focussed category.

• In June 2017, Dentsply Sirona has signed a new distribution agreement with Henry Schein Canada, Inc. in Canada. As per the agreement the company will sell and distribute its consumables products as well as equipment. This agreement helped the company to accelerate its product sales which involves the regenerative bone graft substitutes and membranes.

The company has wide presence across Asia-Pacific, Middle East & Africa, Europe, Americas. The company also has various subsidiary companies such as DENTSPLY Prosthetics U.S. LLC (U.S.), Zephyr Sleep Technologies Inc. (Canada), Dentsply Mexico S.A. de C.V. (Mexico), Dentsply Dental GmbH (Germany), Dentsply Holdings Unlimited (U.K.) and Dentsply Sirona Iberia S.A. (Spain), among others.

Zimmer Biomet

Zimmer Biomet is headquartered in Indiana, U.S. and was founded in 1927. The company is engaged in manufacturing and marketing of innovative solutions that help orthopaedic surgeons and clinicians in improving the quality of life for people around the world by treating pain related symptoms. The company has wide product portfolio including wearable technology, back, chest, dental, elbow, foot & ankle, hip, knee, pectus excavatum, shoulder in which dental is the market focused category.

• In May 2016, Zimmer Biomet Holdings, Inc. has completed the acquisition of Cayenne Medical a company which is involved in the marketing and development of soft tissue repair solution among others. This acquisition helped the company to enhance its product portfolio.

The company has wide presence Americas, Europe, Middle East & Africa, Asia-Pacific. The company also has various subsidiary companies such as Accelero Health Partners, LLC (U.S.), Biomet Holdings US Inc. (U.S.), Dornoch Medical Systems, Inc. (U.S.), Implant Innovations Holdings, LLC (U.S.) and Medtech Surgical, Inc. (U.S.), among others.

Medtronic

Medtronic is headquartered in Dublin, Ireland and was founded in 1949. The company is engaged in manufacturing and marketing of innovative solutions that help orthopaedic surgeons and clinicians in improving the quality of life for people around the world by treating pain related symptoms. The company is engaged in providing wide range of product categories such as advanced surgical technology, cardiac rhythm, cardiovascular, diabetes, digestive and gastrointestinal, ear, nose & throat, general surgery, gynecological, neurological, oral maxillofacial & dental, patient monitoring, renal care, respiratory, spinal & orthopaedic, surgical navigation & imaging and urological in which oral maxillofacial & dental is the market focused product category.

• In February 2019, Medtronic plc launched Grafton(TM) Demineralized Bone Matrix (DBM) bone grafting product in Japan. This product is a bone graft substitute used before the dental implantation procedure. This product launch helped the company to enhance its product portfolio of bone graft substitutes.

The company is has a wide presence in Americas, Europe, Middle East & Africa, Asia-Pacific. The company has several subsidiaries such as Medtronic AVE, Inc. (U.S.), Medtronic Mexico S. de R.L. de C.V. (Canada), Medtronic Comercial Ltda.(Mexico), Medtronic S.A.I.C. (Brazil), Medtronic do Brasil Ltda.(Brazil) and Medtronic Sofamor Danek Deggendorf GmbH (Argentina), among others.